Obesity Featured Articles

  1. When Vendor Disruption Threatens Trial Timelines: What Sponsors Should Do Next 9/30/2026

    When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.

  2. How Plain Language Summaries Created Under EU CTR Can Help Shape NIH Policy 9/30/2026

    As the NIH shapes its plain language summary policy, EU CTR experience offers practical lessons on clarity, privacy, consistency, and implementation.

  3. Most Patients Learn About A Trial Online, But Is That What They Want? 9/30/2026

    Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.

  4. Why U.S. Sponsors Should Conduct Clinical Trials In Australia 9/29/2026

    Faster approvals, refundable tax offsets, and a large patient population raise a pointed question: does Australia now outperform U.S. sites for early trial start-up?

  5. Long-Distance Rare Disease Trials: Why PLL Landed On Australia And New Zealand 9/29/2026

    Australia and New Zealand had a lot to offer PLL Therapeutics, but speed and savings aren't the only upsides for running its rare disease trial from its European home.

  6. Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D? 9/29/2026

    Integrated technology platforms can connect R&D data, accelerate trials, strengthen quality, and cut costs — but successful adoption requires more than AI.

  7. ASCO To EHA 2026: From Incremental Gains To Early Impact: What Biotechs Must Do Next 9/28/2026

    Oncology is moving to earlier treatment. Learn how ASCO and EHA 2026 results can help you design faster, earlier-line trials that stay relevant as standards of care change and access gaps persist.

  8. Meeting The Complexities Of Modern ADC Development 9/28/2026

    A strong molecule is no longer enough. Learn how trial strategy and operational readiness can help your cancer therapy reach patients faster.

  9. Improving Early Phase Oncology Trial Execution With A Site-First Approach 9/28/2026

    Trials that look good on paper often stall at the site. Learn how involving sites early in study design cuts delays and keeps early-phase cancer studies on track from startup to patients.

  10. "How I Feel" – The Critical Role Of The Patient Perspective And How To Collect It 9/28/2026

    Not sure how to capture what patients really experience? Explore five research methods, their strengths and limitations, and how early patient insight can sharpen trial design and development decisions.